How BioNTech, Up 26% Over Four Days, Is Riding Summit’s Coattails To A Recovery
Investor's Business DailyBioNTech stock has climbed 26% over four days as the German biotech rides a round of cancer treatment success from Summit Therapeutics.
The post How BioNTech, Up 26% Over Four Days, Is Riding Summit's Coattails To A Recovery appeared first on Inve…